Figures & data
Figure 1 Schematic representation of patient distribution of PRO data.
![Figure 1 Schematic representation of patient distribution of PRO data.](/cms/asset/83b1ea1a-6367-4239-964d-1739794e6831/dcop_a_117378_f0001_c.jpg)
Figure 2 Frequency distribution of health status assessed by SGRQ-C score according to severity of disease in the ECLIPSE cohort.
Abbreviation: SGRQ-C, St George’s Respiratory Questionnaire for COPD.
![Figure 2 Frequency distribution of health status assessed by SGRQ-C score according to severity of disease in the ECLIPSE cohort.](/cms/asset/64603343-70f8-4a0d-bb5e-e900dad7b4ab/dcop_a_117378_f0002_c.jpg)
Figure 3 Hypothetical incidence of benefit.
![Figure 3 Hypothetical incidence of benefit.](/cms/asset/8e8b66e6-53e4-4d4e-aac2-aa4c8c7cce64/dcop_a_117378_f0003_c.jpg)
Table 1 Hypothetical 6-month SGRQ total scores from a study comparing a LABA/LAMA combination with placebo, LAMA, and LABA